Pacira BioSciences, Inc. (PCRX)

NASDAQ: PCRX · Real-Time Price · USD

Compare

22.77

-1.56 (-6.41%)

At close: Nov 20, 2025, 4:00 PM EST

22.80

+0.03 (0.13%)

After-hours: Nov 20, 2025, 4:10 PM EST

Pacira BioSciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	716.79	700.97	674.98	666.82	541.53	429.65	Upgrade
Revenue Growth (YoY)	3.14%	3.85%	1.22%	23.14%	26.04%	2.05%	Upgrade
Cost of Revenue	246.14	252.01	260.93	284.09	195.8	176.75	Upgrade
Gross Profit	470.65	448.96	414.05	382.73	345.73	252.9	Upgrade
Selling, General & Admin	346.77	294.1	269.44	254.52	199.35	193.52	Upgrade
Amortization of Goodwill & Intangibles	57.29	57.29	57.29	57.29	13.55	7.87	Upgrade
Other Operating Expenses	-	-	-	-	42.91	-	Upgrade
Operating Expenses	405.51	351.39	326.73	311.8	255.81	201.38	Upgrade
Operating Income	65.15	97.57	87.32	70.93	89.92	51.52	Upgrade
Interest Expense	-18.23	-16.57	-20.31	-39.98	-31.75	-25.67	Upgrade
Interest & Investment Income	25.99	19.69	11.44	4.54	0.9	4.63	Upgrade
Other Non Operating Income (Expenses)	-10.73	-0.37	-0.19	-1.29	-0.07	1.23	Upgrade
EBT Excluding Unusual Items	62.18	100.32	78.28	34.21	59	31.71	Upgrade
Merger & Restructuring Charges	-13.03	-9.99	-3.07	-11.25	-	0.04	Upgrade
Impairment of Goodwill	-	-163.24	-	-	-	-	Upgrade
Gain (Loss) on Sale of Investments	4.23	-	-	-10	-2.6	1.62	Upgrade
Asset Writedown	-25.87	-	-	-26.13	-	-	Upgrade
Legal Settlements	16.15	-	-	-	-	-	Upgrade
Other Unusual Items	-1.83	9.81	-13.5	26.48	-	-13.28	Upgrade
Pretax Income	41.83	-63.11	61.7	13.3	56.4	20.09	Upgrade
Income Tax Expense	20.39	36.45	19.75	-2.61	14.42	-125.43	Upgrade
Net Income	21.44	-99.56	41.96	15.91	41.98	145.52	Upgrade
Net Income to Common	21.44	-99.56	41.96	15.91	41.98	145.52	Upgrade
Net Income Growth	-	-	163.72%	-62.10%	-71.15%	-	Upgrade
Shares Outstanding (Basic)	45	46	46	46	44	43	Upgrade
Shares Outstanding (Diluted)	46	46	52	47	46	44	Upgrade
Shares Change (YoY)	-1.02%	-11.03%	11.69%	1.99%	4.46%	5.22%	Upgrade
EPS (Basic)	0.47	-2.15	0.91	0.35	0.95	3.41	Upgrade
EPS (Diluted)	0.47	-2.15	0.89	0.34	0.92	3.33	Upgrade
EPS Growth	-	-	160.68%	-63.04%	-72.37%	-	Upgrade
Free Cash Flow	124.2	178.75	139.49	115.2	79.85	39.23	Upgrade
Free Cash Flow Per Share	2.71	3.87	2.68	2.48	1.75	0.90	Upgrade
Gross Margin	65.66%	64.05%	61.34%	57.40%	63.84%	58.86%	Upgrade
Operating Margin	9.09%	13.92%	12.94%	10.64%	16.61%	11.99%	Upgrade
Profit Margin	2.99%	-14.20%	6.22%	2.39%	7.75%	33.87%	Upgrade
Free Cash Flow Margin	17.33%	25.50%	20.67%	17.28%	14.74%	9.13%	Upgrade
EBITDA	150.57	176.36	162.9	151.93	118.47	71.42	Upgrade
EBITDA Margin	21.01%	25.16%	24.13%	22.78%	21.88%	16.62%	Upgrade
D&A For EBITDA	85.42	78.79	75.57	81	28.55	19.91	Upgrade
EBIT	65.15	97.57	87.32	70.93	89.92	51.52	Upgrade
EBIT Margin	9.09%	13.92%	12.94%	10.64%	16.61%	11.99%	Upgrade
Effective Tax Rate	48.75%	-	32.00%	-	25.57%	-	Upgrade
Revenue as Reported	716.79	700.97	674.98	666.82	541.53	429.65	Upgrade

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q